Phillip Fyman
Interventional Pain Medicine · Syosset, NYNPI 1528050051
Payments from drug & device makers
Across 261 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$467
- AbbVie$408
- Biohaven Pharmaceuticals, Inc.$384
- Scilex Pharmaceuticals Inc.$279
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$238
- Daiichi Sankyo Inc.$228
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,57397%
- Education$1023%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 53 | $467 |
| AbbVie(2 entities) | 33 | $408 |
| Biohaven Pharmaceuticals, Inc. | 13 | $384 |
| Scilex Pharmaceuticals Inc. | 25 | $279 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $238 |
| Daiichi Sankyo Inc. | 16 | $228 |
| Assertio Therapeutics, Inc. | 10 | $155 |
| Eisai Inc. | 11 | $154 |
| AstraZeneca | 6 | $107 |
| Novartis | 6 | $99 |
| Sentynl Therapeutics, Inc. | 7 | $96 |
| Almatica Pharma LLC | 4 | $95 |
| Arbor Pharmaceuticals, Inc. | 5 | $91 |
| Nevro Corp. | 2 | $89 |
| Amgen(2 entities) | 5 | $82 |
| Pfizer | 5 | $80 |
| Redhill Biopharma Inc. | 4 | $73 |
| Shionogi Inc | 3 | $55 |
| Vertical Pharmaceuticals, LLC | 3 | $55 |
| Boston Scientific | 2 | $47 |
| Forte Bio-pharma LLC | 1 | $45 |
| Biodelivery Sciences International, Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $37 |
| Lilly USA, LLC | 3 | $36 |
| GRT US Holding, Inc. | 1 | $36 |
| Indivior Inc. | 2 | $30 |
| Cumberland Pharmaceuticals, Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Orexo US, Inc. | 1 | $14 |
| Abbott | 1 | $14 |
| Virtus Pharmaceuticals LLC | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$182
How this compares
$3,675 in reported general payments places this provider in the 50th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Other interventional pain medicine in Syosset
- Alexander WeingartenSyosset$43K
- Sathish ModuguHartsdale$1.3M
- Neel MehtaNew York$655K
- Corey HunterNew York$571K
- Hemant KaliaRochester$234K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Jafar SiddiquiWilliamsville$70K
- Suelane OuroNew York$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.